Cargando…

Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy

Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms underlying the clinical variability remain poorly understood. To clarify whether different brain cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial DNA (mtDNA) depletion...

Descripción completa

Detalles Bibliográficos
Autores principales: Ignatenko, Olesia, Chilov, Dmitri, Paetau, Ilse, de Miguel, Elena, Jackson, Christopher B., Capin, Gabrielle, Paetau, Anders, Terzioglu, Mugen, Euro, Liliya, Suomalainen, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754366/
https://www.ncbi.nlm.nih.gov/pubmed/29302033
http://dx.doi.org/10.1038/s41467-017-01859-9
_version_ 1783290399677218816
author Ignatenko, Olesia
Chilov, Dmitri
Paetau, Ilse
de Miguel, Elena
Jackson, Christopher B.
Capin, Gabrielle
Paetau, Anders
Terzioglu, Mugen
Euro, Liliya
Suomalainen, Anu
author_facet Ignatenko, Olesia
Chilov, Dmitri
Paetau, Ilse
de Miguel, Elena
Jackson, Christopher B.
Capin, Gabrielle
Paetau, Anders
Terzioglu, Mugen
Euro, Liliya
Suomalainen, Anu
author_sort Ignatenko, Olesia
collection PubMed
description Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms underlying the clinical variability remain poorly understood. To clarify whether different brain cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial DNA (mtDNA) depletion in either neurons or astrocytes of mice, by inactivating Twinkle (TwKO), the replicative mtDNA helicase. Here we show that astrocytes, the most abundant cerebral cell type, are chronically activated upon mtDNA loss, leading to early-onset spongiotic degeneration of brain parenchyma, microgliosis and secondary neurodegeneration. Neuronal mtDNA loss does not, however, cause symptoms until 8 months of age. Findings in astrocyte-TwKO mimic neuropathology of Alpers syndrome, infantile-onset mitochondrial spongiotic encephalopathy caused by mtDNA maintenance defects. Our evidence indicates that (1) astrocytes are dependent on mtDNA integrity; (2) mitochondrial metabolism contributes to their activation; (3) chronic astrocyte activation has devastating consequences, underlying spongiotic encephalopathy; and that (4) astrocytes are a potential target for interventions.
format Online
Article
Text
id pubmed-5754366
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57543662018-01-12 Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy Ignatenko, Olesia Chilov, Dmitri Paetau, Ilse de Miguel, Elena Jackson, Christopher B. Capin, Gabrielle Paetau, Anders Terzioglu, Mugen Euro, Liliya Suomalainen, Anu Nat Commun Article Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms underlying the clinical variability remain poorly understood. To clarify whether different brain cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial DNA (mtDNA) depletion in either neurons or astrocytes of mice, by inactivating Twinkle (TwKO), the replicative mtDNA helicase. Here we show that astrocytes, the most abundant cerebral cell type, are chronically activated upon mtDNA loss, leading to early-onset spongiotic degeneration of brain parenchyma, microgliosis and secondary neurodegeneration. Neuronal mtDNA loss does not, however, cause symptoms until 8 months of age. Findings in astrocyte-TwKO mimic neuropathology of Alpers syndrome, infantile-onset mitochondrial spongiotic encephalopathy caused by mtDNA maintenance defects. Our evidence indicates that (1) astrocytes are dependent on mtDNA integrity; (2) mitochondrial metabolism contributes to their activation; (3) chronic astrocyte activation has devastating consequences, underlying spongiotic encephalopathy; and that (4) astrocytes are a potential target for interventions. Nature Publishing Group UK 2018-01-04 /pmc/articles/PMC5754366/ /pubmed/29302033 http://dx.doi.org/10.1038/s41467-017-01859-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ignatenko, Olesia
Chilov, Dmitri
Paetau, Ilse
de Miguel, Elena
Jackson, Christopher B.
Capin, Gabrielle
Paetau, Anders
Terzioglu, Mugen
Euro, Liliya
Suomalainen, Anu
Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title_full Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title_fullStr Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title_full_unstemmed Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title_short Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
title_sort loss of mtdna activates astrocytes and leads to spongiotic encephalopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754366/
https://www.ncbi.nlm.nih.gov/pubmed/29302033
http://dx.doi.org/10.1038/s41467-017-01859-9
work_keys_str_mv AT ignatenkoolesia lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT chilovdmitri lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT paetauilse lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT demiguelelena lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT jacksonchristopherb lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT capingabrielle lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT paetauanders lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT terzioglumugen lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT euroliliya lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy
AT suomalainenanu lossofmtdnaactivatesastrocytesandleadstospongioticencephalopathy